Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.17
Tweet
Share
E-mailGet Alerts CPIX Hot Sheet
Join SI Premium – FREE
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.17. Revenue for the quarter came in at $40 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi turns more bullish on trucking stocks
- Hyperion DeFi raises FY26 guidance, launches $20M buyback
- MSC Industrial names Rob Kuhns as executive VP and CFO
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
